| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Innovet Bovine Herd Health Consultancy, Noordbeemster, 1463 PJ, The Netherlands
2 Department of Farm Animal Health, Utrecht University, PO Box 80851, 3508 TD Utrecht, The Netherlands
3 Quality Milk Production Services, Cornell University, Ithaca, NY, 14850-1263
Corresponding author: J. M. Swinkels; e-mail: swinkels{at}innovet.nl.
Subclinical Staphylococcus aureus mastitis is rarely treated during lactation because it is widely believed to be uneconomical, although there are no economic studies that support this view. Partial budgeting was used to develop a deterministic simulation model to estimate the net cost or benefit of antibiotic treatment of subclinical S. aureus mastitis during lactation. Direct and indirect effects of treatment were taken into account, including prevention of clinical flare-ups and contagious transmission. Input variables were based on literature and on 2003–2004 prices in the Netherlands. When contagious transmission of S. aureus was likely (reproductive ratio R = 5.3), 3- and 8-d treatments resulted in an average net profit of 
95.62 and 142.42, respectively, compared with no treatment. When the probability of S. aureus transmission was low (R = 0.32), the average economic benefit of 3- or 8-d treatment was – 21.12 and – 57.70, respectively. On low-transmission farms, 3-d treatment was profitable when the appropriate cows were selected for treatment using known risk factors for cure. Sensitivity analysis showed that the 6 most influential input variables in the model were chance of bacteriological cure, R, probability of culling, retention pay-off, and cost of antibiotics and bacterial culture. Although the economic outcome of lactational treatment of subclinical S. aureus mastitis is highly herd-, cow-, and strain-dependent, treatment is economically justified in many situations.
Key Words: Staphylococcus aureus • treatment • economic • partial budget
Abbreviation key: BMSCC = bulk milk somatic cell count, PC = probability of cure, PR = penicillin-resistant, PS = penicillin-sensitive, R = reproductive ratio, RPO = retention pay-off.
This article has been cited by other articles:
|
|
 |
|
  J. E. Breen, A. J. Bradley, and M. J. Green Quarter and cow risk factors associated with a somatic cell count greater than 199,000 cells per milliliter in United Kingdom dairy cows J Dairy Sci, July 1, 2009; 92(7): 3106 - 3115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Halasa, M. Nielen, A. P. W. De Roos, R. Van Hoorne, G. de Jong, T. J. G. M. Lam, T. van Werven, and H. Hogeveen Production loss due to new subclinical mastitis in Dutch dairy cows estimated with a test-day model J Dairy Sci, February 1, 2009; 92(2): 599 - 606. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Salat, F. Serieys, B. Poutrel, L. Durel, and L. Goby Systemic Treatment of Subclinical Mastitis in Lactating Cows with Penethamate Hydriodide J Dairy Sci, February 1, 2008; 91(2): 632 - 640. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Reksen, L. Solverod, and O. Osteras Relationships Between Milk Culture Results and Milk Yield in Norwegian Dairy Cattle J Dairy Sci, October 1, 2007; 90(10): 4670 - 4678. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Reksen, L. Solverod, A. J. Branscum, and O. Osteras Relationships between milk culture results and treatment for clinical mastitis or culling in Norwegian dairy cattle. J Dairy Sci, August 1, 2006; 89(8): 2928 - 2937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Barkema, Y. H. Schukken, and R. N. Zadoks Invited Review: The role of cow, pathogen, and treatment regimen in the therapeutic success of bovine Staphylococcus aureus mastitis. J Dairy Sci, June 1, 2006; 89(6): 1877 - 1895. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
